Assistant Professor of Surgery, Academic Institute
Assistant Member, Research Institute
Houston Methodist
Weill Cornell Medical College
I am interested in understanding how epigenetic changes contribute to tumorigenesis, disease progression and the development of therapy resistance, and how we can exploit these aberrations to engineer novel therapeutic approaches. In the lab, we utilize experimental, computational, and high-throughput technologies to study and modulate the epigenetic changes in cancer with the goal of (1) identifying the epigenetic drivers of cancer development and progression (2) identifying epigenetic alterations and the mechanisms underlying targeted and immuno-therapy resistance (3) exploit novel epigenetic targets and develop therapeutic strategies.